Aerpio Pharmaceuticals, Inc.
Methods of treating intraocular pressure with activators of Tie-2
Last updated:
Abstract:
Disclosed herein are compounds effective for activation of Tie-2 and inhibition of HPTP-beta. The compounds can provide effective therapy for eye conditions associated with angiogenesis, for example, intraocular pressure, ocular hypertension, and glaucoma.
Status:
Grant
Type:
Utility
Filling date:
22 Sep 2016
Issue date:
23 Mar 2021